Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (CL-010)
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The trial will evaluate the extended bactericidal activity of 14 consecutive days of oral
administration of PA-824 at 50, 100, 150 and 200 mg per day in adult patients with newly
diagnosed, uncomplicated, smear positive tuberculosis (TB). A control group will receive
standard TB treatment.